Skip to content
  • Log In
    • Healthcare Providers
  • Careers
  • Contact
OM1 outcomes & advanced analytics

  • Solutions
    • RWD & Data Networks
        • Specialty Areas
          • Mental Health & Neuroscience
          • Cardiometabolic
          • Dermatology
          • Gastroenterology
          • Respiratory/ENT
          • Rheumatology
        • Build Your Own Data Network
          • Custom Data Cohorts
        • Analytics & Data Visualization
          • Research Analytics
          • Partner Analytics
    • AI & Predictive Medicine
        • OM1 Patient Finder
        • Rare Disease
        • OM1 Joint Insights
        • OM1 Medical Burden Index
  • About
    • Leadership
    • Careers
    • Contact
  • Resources
    • Solutions
      • RWD & Data Networks
        • Specialty Areas
          • Mental Health & Neuroscience
          • Cardiometabolic
          • Dermatology
          • Gastroenterology
          • Respiratory/ENT
          • Rheumatology
        • Build Your Own Data Network
          • Custom Data Cohorts
        • Analytics & Data Visualization
          • Research Analytics
          • Partner Analytics
      • AI & Predictive Medicine
        • OM1 Patient Finder
        • Rare Disease
        • OM1 Joint Insights
        • OM1 Medical Burden Index
    • About
      • Leadership
      • Careers
      • Contact
    • Resources
    • Log In
      • Healthcare Providers
    • Careers
    • Contact
RESOURCES

Using Real-World Data to Understand Patient Journeys in Dermatology

Listen to OM1’s podcast episode on the Medical Affairs Professional Society (MAPS) “Elevate” podcast series. Dr. Stefan Weiss is discussing ways to transform the way we conduct safety studies — relying more on EMR patient data overlain with technology to create a more accurate and equitable view of post-market safety. Moving away from cumbersome and[…]

› LISTEN TO THE PODCAST

POSTERS

POSTERS

Impact of Change in Biologic Disease Modifying Antirheumatic Drug Therapy on Disease Activity Measures: Findings from a Large Contemporaneous Real-World Longitudinal Database of Psoriatic Arthritis Patients

DEC 2, 2022

View our poster on Impact of Change in Biologic Disease Modifying Antirheumatic Drug Therapy on Disease Activity Measures: Findings from a Large Contemporaneous Real-World Longitudinal Database of Psoriatic Arthritis Patients. Click to view!

POSTERS

Effect of Patient Reported Outcomes on Changes in DMARD Therapy Among Rheumatoid Arthritis Patients Treated in Routine Clinical Practice

DEC 2, 2022

View our poster on Effect of Patient Reported Outcomes on Changes in DMARD Therapy Among Rheumatoid Arthritis Patients Treated in Routine Clinical Practice. Click to view more!

› VIEW ALL POSTERS

EVENTS

EVENTS

SCOPE Summit for Clinical Ops Executives

JAN 27, 2023

When: February, 6-9, 2023 Where: Rosen Shingle Creek in Orlando, FL Booth Location: Find our experts at booth #100 Don’t miss out on our presentation on Getting the Most out of Structured and Unstructured Real-World Data for Evidence Generation. Presenter: Jess Paulus, VP of Research, OM1 Date: Wednesday, February 8 Time: 12:50 PM – 1:20[…]

EVENTS

Visit us at the Crohn’s & Colitis Congress

JAN 11, 2023

When: January 19th-21st, 2023 Where: The Gaylord Rockies Convention Center, Denver, CO Booth Location: Find our experts in booth #619 Leveraging our extensive clinical networks and artificial intelligence (AI) platform, OM1 offers industry-leading enriched healthcare datasets, research analytics, data modeling, decision support, and retrospective and prospective clinical studies. With a focus on high-quality data and[…]

› VIEW ALL EVENTS
JAN 11, 2023

2022 Year in Review: Real-World Data & AI

JAN 27, 2023

SCOPE Summit for Clinical Ops Executives

EBOOKS

EBOOKS

Findings from OM1 Real-World Data: Rheumatoid Arthritis, Heart Failure, Depression, and Schizophrenia

JAN 11, 2023

At OM1, we use both RWD  to create digital data networks and AI powered tools to answer research questions and  improve patient outcomes. In this E-Book you will find a sampling of posters  detailing  studies that address questions in: Rheumatoid Arthritis Heart Failure Depression Schizophrenia Systemic Lupus Erythematosus Real-World Data Methodologies And more! Download >>[…]

EBOOKS

Analyses & Insights from OM1 Heart Failure Datasets

JAN 11, 2023

At OM1, we use both RWD to create digital data networks and AI powered tools to answer research questions and improve patient outcomes. In this E-Book you will find a sampling of posters and case studies that address questions in Heart Failure with solutions and considerations in AI and predictive modeling. Download >> *Due to[…]

› VIEW ALL EBOOKS

NEWS & ARTICLES

NEWS & ARTICLES

Kazuki Yoshida, MD, MPH, ScD: Methotrexate Access in the Post-Roe v Wade Era

DEC 2, 2022

Published: December 1, 2022 Rheumatology Network Read the Full Article >> In the wake of the Supreme Court’s decision to overturn Roe v Wade, results of a recent study indicated that more than half of female patients treated with methotrexate, a commonly-prescribed drug used to manage rheumatic diseases, lived in states with abortion restrictions or[…]

NEWS & ARTICLES

Validation of a machine learning approach to estimate expanded disability status scale scores for multiple sclerosis

DEC 2, 2022

Published: June 22, 2022 Sage Journals Read the Full Article >> Background: Disability assessment using the Expanded Disability Status Scale (EDSS) is important to inform treatment decisions and monitor the progression of multiple sclerosis. Yet, EDSS scores are documented infrequently in electronic medical records. Objective: To validate a machine learning model to estimate EDSS scores[…]

› VIEW ALL NEWS & ARTICLES

WHITE PAPERS

WHITE PAPERS

From Big Data to Measurable Outcomes: OBC

JUL 6, 2017

A heightened focus on value is driving efforts across health care to improve outcomes and reduce costs. For pharmaceutical companies, this focus translates into a shift away from traditional payment models to more outcomes-based, risk sharing agreements. In many ways, these agreements present the opportunity to better align interests across health care’s stakeholders. However, they[…]

WHITE PAPERS

Improving Performance under Bundled Care

NOV 5, 2016

The field of medicine is changing rapidly due to two major disruptions – the application of artificial intelligence, such as machine and deep learning and the shift from fee-for-service to value-based payment models. These innovations, which are occurring simultaneously, are fundamentally altering how data are used and how care is provided. To survive in this[…]

› VIEW ALL WHITE PAPERS

WEBINARS

WEBINARS

Getting the Most out of Structured and Unstructured Real-World Data for Evidence Generation

JAN 20, 2023

Tue, Feb 21, 2023 2:00 PM – 3:00 PM EST Presenters: Jessica Paulus, ScD, VP of Research, OM1 and Anna Swenson, Senior Epidemiologist, OM1 Register >>  Structured data, what’s found in an electronic medical record or claims, and unstructured data, what’s found in clinician notes, provide valuable insights into treatment effectiveness and safety, gaps in[…]

WEBINARS

Using AI to Accelerate Diagnosis and Treatment

DEC 5, 2022

In this episode of the Medical Affairs Professional Society (MAPS) podcast ELEVATE, Joseph Zabinski, PhD, Senior Director, AI & Personalized Medicine at OM1 discusses how Artificial Intelligence can accelerate diagnosis and treatment. Listen to the Full Episode >>

› VIEW ALL WEBINARS
31 St. James Ave Suite #1125
Boston MA, 02116
+1 (888) 324 3899
  • Solutions
  • About
  • Resources
  • Login
  • Careers
  • Contact

2023 © Copyright OM1, All rights reserved. Privacy | Terms of Use

2023 © Copyright OM1, All rights reserved.

Privacy | Terms of Use